Can this agreement be signed electronically?

Yes. Electronic signatures are generally legally binding under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided intent, consent, attribution, and retrievability are satisfied; beware statutory exceptions such as certain court orders and testamentary documents.

Do healthcare forms require special disclosures for e-signatures?

Consumer-facing healthcare records that affect benefits or financial transactions may require an ESIGN consumer disclosure and confirmation of access; follow 15 U.S.C. §7001(c) guidance and institutional policy.

Is RON acceptable for notarizing this agreement?

Remote online notarization is allowed where a state permits RON; confirm state notary rules and identity-proofing requirements (KBA, credential analysis, audio-video recording) before using RON.

What happens if a DEA number is wrong on the agreement?

An incorrect or expired DEA number can undermine prescribing or dispensing authority and trigger audits or disciplinary action; verify numbers before execution and correct errors promptly in a documented amendment.

How long must I retain the signed agreement?

Follow federal minimums and applicable industry rules: at least 3 years for many financial records (IRC §6501(a)) and 6 years for HIPAA-related records (45 CFR §164.530(j)); state law may require longer retention.

How do I revoke or amend the agreement?

Amendments should be executed in writing and signed by authorized parties; revoke only per contract terms and document notice and transition steps for patient safety and regulatory reporting.

Electronic Signature
Templates
Healthcare
Healthcare Controlled Substance Agreement

Healthcare Controlled Substance Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Controlled Substance Agreement

This Controlled Substance Agreement documents the mutual responsibilities of the Provider and the Patient with respect to the evaluation, treatment, and prescribed use of controlled substances. Patient Name: . Provider/Practice Name: . Agreement Date:

Patient Information

Full Legal Name Date of Birth Gender Address Phone Email Emergency Contact (Name / Relationship / Phone)

Insurance Information

Insurance Provider Policy Number Group Number Subscriber Name

Medical History

Current Medications Allergies Prior Surgeries Chronic Conditions

Controlled Substance Treatment Plan

Medication Name Dose and Strength Frequency / Directions Route of Administration

Start Date:

Expected Duration:

Max Daily Dose:

Quantity per Prescription Refill Policy (Provider) Medication Class (check all that apply) Opioid Benzodiazepine Stimulant Muscle Relaxant Sedative Other:

Agreement Terms and Informed Consent

I understand that the purpose of controlled substance therapy is to manage symptoms where benefits are expected to outweigh risks. I have received information about the risks, side effects, and alternatives, including the risk of dependence, tolerance, overdose, respiratory depression, cognitive impairment, and interaction with alcohol or other sedating medications.

I agree to the following terms as conditions to receive controlled substances from this Provider. I acknowledge that failure to comply with these conditions may result in modification, tapering, or immediate discontinuation of controlled substance prescriptions and may result in discharge from the practice.

Patient Responsibilities (initial beside each)

I will obtain controlled substances only from the prescribing Provider and will use only one pharmacy for all controlled medications. Pharmacy Name: Phone:

I will not share, sell, or alter medications, and I will store medications securely to prevent theft or misuse.

I will not use illicit drugs or illicitly obtained prescription medications while receiving controlled substances from this Provider.

I will take medications only as prescribed and will not increase dose without Provider authorization.

I will report all prescribed and over-the-counter medications, supplements, and any adverse reactions or side effects promptly.

Monitoring and Testing

To reduce the risk of misuse and diversion, I consent to the following monitoring measures as part of my treatment plan and authorize the Provider to obtain and review state prescription monitoring program records and pharmacy dispensing data.

I consent to provider access to prescription monitoring program data and pharmacy records. I consent to random urine, blood, saliva, or other drug screening at the Provider's discretion. I agree to provide medication bottles for pill counts upon request. I consent to periodic pill counts and surrender of unused medication when requested.

Refills, Lost/Stolen Medications, and Early Refills

Refills will be provided according to the Provider's written refill policy and only during scheduled visits unless otherwise authorized. Lost or stolen medications will not be routinely replaced; replacement may be provided at the Provider's discretion after verification such as a police report. Early refills will not be provided for lost, misplaced, or intentionally destroyed medication.

Termination of Agreement

The Provider reserves the right to discontinue controlled substance prescriptions at any time for noncompliance, evidence of diversion, violation of this Agreement, or clinical concerns. If controlled substance therapy is discontinued, the Provider will offer a plan for tapering where clinically appropriate and provide alternative care or referral when feasible.

Privacy and Authorization

I authorize the Provider to share relevant medical and prescription information with pharmacies, consulting clinicians, and authorized state agencies as necessary to coordinate care and comply with legal reporting obligations. I understand that data may be disclosed to law enforcement if diversion or illegal activity is suspected.

I acknowledge that I have received the practice's privacy notice and information about controlled substance prescribing risks. Authorization Expiration Date

Acknowledgment and Certification

By signing below I certify that I have read, understand, and agree to comply with the terms of this Controlled Substance Agreement. I understand the risks and agree to cooperate with monitoring and treatment recommendations. I acknowledge that my Provider may modify treatment in the interest of my safety and public health.

Patient Name:

Signature:

Date:

If signed by guardian or representative, indicate relationship

What a Healthcare Controlled Substance Agreement Is

Healthcare Controlled Substance Agreement is a written contract used by licensed practitioners, pharmacies, and healthcare organizations to set terms for prescribing, dispensing, or handling controlled substances. It documents responsibilities, monitoring, permitted uses, storage, inventory audits, and diversion prevention measures between parties. The agreement typically includes scope of authority, reporting obligations, compliance with federal and state controlled substances laws, and procedures for suspected misuse. It supports recordkeeping, audit readiness, and patient safety while clarifying consequences for violations. Often executed along with HIPAA authorizations and facility policies.

Why organizations use this agreement

A Healthcare Controlled Substance Agreement centralizes obligations that reduce diversion risk, improve compliance with federal and state law, and document auditing and reporting procedures. It provides a clear basis for enforcement actions and demonstrates good-faith efforts to protect patients and controlled substances.

Common parties who prepare or sign the agreement

Parties involved in Healthcare Controlled Substance Agreements include prescribers, pharmacies, healthcare organizations, and compliance officers responsible for controlled-substance oversight.

Physicians and advanced practice providers managing controlled medication prescribing and monitoring.
Pharmacies and pharmacists overseeing dispensing, inventory control, and recordkeeping for scheduled drugs.
Hospitals, clinics, and compliance officers enforcing policies, audits, and reporting obligations.

Use agreements to assign roles, clarify oversight practices, and provide documentary evidence for internal and regulatory audits.

Core sections to include in a professional agreement

Core sections define authority, monitoring, recordkeeping, diversion response, training, and limits on prescribing to meet regulatory and organizational requirements.

Scope

Defines parties, clinical settings, types of controlled substances covered, and authorized prescribers or dispensers; clarifies permitted uses and any patient eligibility criteria and referral or consultation requirements.

Authority

Specifies delegation of prescribing authority, supervisory relationships, credentialing, and verification steps for prescribers; includes termination of privileges when compliance fails and periodic revalidation requirements.

Monitoring

Describes required patient monitoring, urine drug testing, PDMP checks, frequency of reviews, documentation standards, and escalation pathways for aberrant behavior, including follow-up timelines and responsible personnel.

Recordkeeping

Lists documents to keep: prescriptions, dispensing logs, inventory audits, incident reports, training records, and audit trails; sets retention periods and access controls with electronic logging and tamper-evident measures.

Diversion Response

Outlines procedures for suspected diversion, internal investigations, reporting to licensing boards and DEA, disciplinary actions, and corrective plans, and timelines for notification and evidence preservation.

Training

Specifies mandatory staff training topics, frequency, record of completion, competency assessments, and responsibilities for maintaining compliance, including controlled-substance handling, diversion awareness, and security protocols with annual refreshers.

Sequential checklist to prepare and implement the agreement

Follow this sequential checklist to prepare, review, authorize, and implement the agreement within your organization.

01

Prepare: Gather licenses, DEA/NPI, and facility policies.
02

Draft: Document scope, monitoring, and reporting procedures.
03

Review: Obtain legal and compliance sign-off before execution.
04

Execute: Collect signatures, notarize if required, and distribute copies.

How to configure an online workflow for this agreement

Configure your online workflow to match routing, authentication, and audit requirements for controlled substances and storage.

Field	Configuration
Signing Order	Define approval sequence and conditional signers for clinical and compliance review.
Authentication	Use email plus SMS codes or SSO; consider stronger verification for high-risk signers.
Notarization	Enable remote online notarization (RON) when allowed by state law and institutional policy.
Retention	Automatic encrypted archival with audit trail and access controls.

Typical submission and routing flow

Typical routing and submission paths for completed agreements, and who receives copies for regulatory and internal records.

Sender: Uploads document, places fields, and assigns signers.
Signer: Authenticates and signs the agreement electronically.
Notary: Performs acknowledgment where notarization is required (in-person or RON).
Records: Final signed copy and audit trail are stored for retention and audits.

Platform capabilities to support controlled-substance workflows

Use a platform that supports HIPAA, audit trails, and flexible authentication for controlled substances and encrypted storage.

Formats: PDF, DOCX, and fillable forms
Integrations: EHR, pharmacy, and SSO systems
Security: MFA, audit trail, access controls

Key timelines and time-sensitive obligations

Time-sensitive items and regulatory deadlines related to controlled substance agreements and reporting obligations, including PDMP checks and renewal dates.

DEA Registration Renewal:

Check renewal cycles; expired DEA numbers revoke prescribing authority immediately.

PDMP Checks Frequency:

Perform checks at initiation and at intervals required by state law or policy.

Incident Reporting Timeline:

Report suspected diversion promptly per state and institutional policy, often within 24–72 hours.

Notary/Execution Deadlines:

Complete notarization or witness steps before controlled prescribing activities begin.

Record Retention Start Date:

Retention counts from document creation or last effective date per HIPAA and federal record rules.

Consequences and enforcement risks of noncompliance

License Sanctions: Suspension or revocation

Criminal Liability: Felony charges for diversion

Civil Damages: Lawsuits and indemnity claims

DEA Fines: Administrative penalties and investigations

Operational Impact: Program suspension, increased audits

Record Penalties: Failure to keep required records invites enforcement

Security and compliance controls to include

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

HIPAA: BAA required; PHI protection standards

Audit Trail: Timestamps, IP addresses, and action history retained

Access Control: Role-based access and MFA recommended

Notarization: Supports remote online notarization (RON) and in-person options

Compliance: ESIGN, UETA, and 21 CFR Part 11 support

Real-world examples of electronic agreement use

Practical examples highlight how e-agreements streamline approvals, preserve audit trails, and reduce administrative delay.

Fertility Centers of Illinois

Fertility Centers standardized controlled-substance authorizations and patient consents using electronic agreement templates to reduce processing time and improve audit readiness.

API integration and audit trails ensured traceability.
John Butler reported: "The airSlate SignNow team has been exceptional, responsive, the API has been great, and we're extremely happy that we chose airSlate SignNow as a company." — Founder, Fertility Centers of Illinois.

Optica Ventures LLC

Optica Ventures used e-agreements to streamline partner approvals and reduce turnaround time for controlled-substance handling agreements across multiple portfolios.

Simplified interface improved external counterparty completion rates.
Brian Fitzgibbons said: "The interface is simple and easy-to-use for our team; more importantly, it is just as easy for our customers." — COO, Optica Ventures LLC.

Practical tips for reliable agreement management

Apply consistent controls and review procedures to reduce errors and strengthen defensibility during audits or investigations.

Verify credentials and registrations

Confirm practitioner DEA and NPI numbers before signing; document active status checks and re-verify periodically to prevent unauthorized prescribing.

Limit privileges clearly

Define scope and limits on prescribing (drug lists, dose maximums, duration) to reduce ambiguity and support clinical decision-making.

Use audit-ready templates

Standardize clauses, include required monitoring steps, and ensure audit trails capture timestamps, IP addresses, and signer identity evidence.

Coordinate with compliance

Involve legal, compliance, pharmacy, and IT early to align on retention, BAA requirements, authentication strength, and notification workflows.

Sample eSignature vendor pricing and capability snapshot

Compare basic plan pricing and select capabilities when evaluating e-signature options for Healthcare Controlled Substance Agreements.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes (Business Premium)	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes (BAA available)	Yes	Yes	No	No
Envelope Cap	No envelope cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently asked questions about executing and enforcing the agreement

Answers to common questions about electronic execution, notarization, recordkeeping, and legal enforceability for Healthcare Controlled Substance Agreements.

Need help? Contact support

Can this agreement be signed electronically?
Yes. Electronic signatures are generally legally binding under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted, provided intent, consent, attribution, and retrievability are satisfied; beware statutory exceptions such as certain court orders and testamentary documents.
Do healthcare forms require special disclosures for e-signatures?
Consumer-facing healthcare records that affect benefits or financial transactions may require an ESIGN consumer disclosure and confirmation of access; follow 15 U.S.C. §7001(c) guidance and institutional policy.
Is RON acceptable for notarizing this agreement?
Remote online notarization is allowed where a state permits RON; confirm state notary rules and identity-proofing requirements (KBA, credential analysis, audio-video recording) before using RON.
What happens if a DEA number is wrong on the agreement?
An incorrect or expired DEA number can undermine prescribing or dispensing authority and trigger audits or disciplinary action; verify numbers before execution and correct errors promptly in a documented amendment.
How long must I retain the signed agreement?
Follow federal minimums and applicable industry rules: at least 3 years for many financial records (IRC §6501(a)) and 6 years for HIPAA-related records (45 CFR §164.530(j)); state law may require longer retention.
How do I revoke or amend the agreement?
Amendments should be executed in writing and signed by authorized parties; revoke only per contract terms and document notice and transition steps for patient safety and regulatory reporting.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now